Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

The future of the Bay Area biotech firm Allakos was riding on one clinical trial, for a drug designed to treat the skin ...

Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to ...

Biotechnology venture capital is recovering from its slide and investors are expressing optimism about 2025, even as they ...

SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

AI, biotech and affordable clean energy will be the focus of an EU drive to make the bloc globally competitive and ensure it ...

A Bay Area biotech is suing its insurance company to cover costs associated with patients allegedly injured during clinical ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Stay ahead in 2025 with the latest biotech deals. Discover key collaborations, M&A, and strategic moves shaping the ...

Curie.Bio, the biotech accelerator and investment firm, has raised another $340 million to invest in startups.

Stay updated on biotech layoffs in 2025! Each week, we track and analyze industry layoffs, their causes, and their impact.